Insider Selling: Intuitive Surgical, Inc. (NASDAQ:ISRG) VP Sells 810 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) VP Fredrik Widman sold 810 shares of Intuitive Surgical stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the completion of the transaction, the vice president now directly owns 473 shares of the company’s stock, valued at approximately $271,397.94. This represents a 63.13 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG traded down $6.17 during mid-day trading on Monday, reaching $566.98. 1,705,279 shares of the company traded hands, compared to its average volume of 1,732,928. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm has a market cap of $201.95 billion, a PE ratio of 88.45, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39. The stock has a fifty day simple moving average of $570.66 and a 200-day simple moving average of $530.08.

Hedge Funds Weigh In On Intuitive Surgical

Hedge funds have recently modified their holdings of the company. Atala Financial Inc bought a new position in Intuitive Surgical during the fourth quarter valued at about $25,000. Hurley Capital LLC bought a new position in shares of Intuitive Surgical during the 4th quarter valued at about $28,000. Berbice Capital Management LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $26,000. Parvin Asset Management LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $26,000. Finally, BankPlus Trust Department acquired a new stake in Intuitive Surgical during the fourth quarter valued at approximately $28,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms have recently commented on ISRG. BTIG Research lifted their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. CICC Research assumed coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price on the stock. Jefferies Financial Group upped their target price on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Royal Bank of Canada raised their price target on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Finally, Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.